Recorded: EIP 2021 ● Language: English ● Duration: 118 minutes ● Topic: Pediatric Infectious Diseases

Moderator: Elizabeth Whittaker

Presentation 1: COVID infection and Pneumococcal Disease
George Syrogiannopoulos (GR)
Learning Objectives: (1) Whether changes in the nasopharyngeal carriage of Streptococcus pneumoniae occurred during the pandemic. (2) The incidence of pneumococcal disease in different parts of the world during the early and late COVID period. (3) The possibility to have a co-infection of SARS-CoV-2 and Streptococcus pneumonia.

Presentation 2: Back to Business: Eliminating Severe RSV Infection
Louis Bont (NL)
Learning Objectives: (1) Understanding the structure of the RSV prefusion (F) protein conformation (2) Understanding mechanism and developmental stage of next-generation RSV F monoclonal antibodies (3) Understanding mechanism and developmental stage of RSV vaccine development COVID pneumonia and the role of treatments in vulnerable children

Presentation 3: COVID pneumonia and the role of treatments in vulnerable children
Elizabeth Whittaker (UK)
Learning Objectives: (1) Understand the epidemiology of COVID-19 in children and young people (2) Identify which children are most at risk of severe disease following SARS-CoV-2 infection (3) Overview of evidence for current treatment for the management of COVID-19 pneumonia (4) Review of possible protective measures for vulnerable CYP (including vaccines, monoclonal antibodies and anti-viral treatments) Severe Pneumonia – More than the Usual Suspects

Presentation 4: Severe Pneumonia – More than the Usual Suspects
Debby Bogaert (UK)
Learning Objectives:(1) Learn about the importance of mucosal homeostasis in the prevention of infection (2) Understand the role of healthy commensals in preventing and modulating respiratory infection (3) Learn about the complex interactions between host, microbiome and environment underpinning (severe) infections